Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's
Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...
You Just Found Out You Have Crohn's Disease—Here Are 6 Things Gastroenterologists Recommend You Do First
If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, ...
GlobalData on MSN3d
EMA CHMP recommends Lilly’s Crohn’s therapy for EU approval
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Omvoh ...
Teva, Sanofi say bowel disease drug met primary targets
Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...
Pharmabiz7h
Sanofi & Teva Pharma’s RELIEVE UCCD phase 2b study of duvakitug in ulcerative colitis and Crohn’s disease meets primary endpoints
and Crohn’s disease (CD). RELIEVE UCCD assessed duvakitug, a human IgG1-?2 monoclonal antibody targeting TL1A, for the treatment of moderate-to-severe inflammatory bowel disease (IBD). In the RELIEVE ...
South Jersey clinic using intestinal ultrasound as an alternative for people with inflammatory bowel disease
A device used in South Jersey is a game-changer for people with inflammatory bowel disease as an alternative to invasive ...
Medscape12h
FDA Approves Seventh Ustekinumab Biosimilar, Steqeyma
Ustekinumab-stba, manufactured by Celltrion, is expected to be marketed in the United States in February 2025.
Armed robbery in Revesby1d
Key Fibrosis Driver in Crohn's Disease Found
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...
FierceBiotech2d
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
Medscape4h
Noninvasive Microbiome Test May Specifically Identify Crohn’s and Ulcerative Colitis
Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...
emjreviews.com3d
Lilly gains EU backing for drug to treat Crohn’s disease
The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).
Researchers identify key driver of fibrosis in Crohn's disease
Crohn's disease, a type of chronic inflammatory bowel disease (IBD), often causes scar-like tissue to build up in the ...